TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 • 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

November 17, 2017 • 00:27:56
Episode Cover

Mechanical Circulatory Support Devices

What do you do for the patient in cardiogenic shock who is not responding to vasopressors and inotropes?  Should you place a mechanical circulatory...

Listen

Episode 0

April 13, 2023 • 00:28:58
Episode Cover

Should We Administer Steroids in Severe CAP?

In recent years,  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.  In this podcast, we...

Listen

Episode 0

February 01, 2022 • 00:20:19
Episode Cover

EM-STAT!

Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.  In this podcast, we...

Listen